Johnson Chemical Pharmaceutical Works Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 11, 2022 at 05:08 pm
Share
Johnson Chemical Pharmaceutical Works Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 126.58 million compared to TWD 100.35 million a year ago. Net income was TWD 19.24 million compared to TWD 13.28 million a year ago. Basic earnings per share from continuing operations was TWD 0.64 compared to TWD 0.44 a year ago. Diluted earnings per share from continuing operations was TWD 0.64 compared to TWD 0.44 a year ago.
For the nine months, sales was TWD 353.54 million compared to TWD 304.99 million a year ago. Net income was TWD 46.3 million compared to TWD 36.59 million a year ago. Basic earnings per share from continuing operations was TWD 1.54 compared to TWD 1.22 a year ago. Diluted earnings per share from continuing operations was TWD 1.54 compared to TWD 1.22 a year ago.
Johnson Chemical Pharmaceutical Works Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of western medicines and the related raw materials. The Company mainly provides solid dosage forms, including soft and hard capsules, sugar coated tablets, film-coated tablets, suppositories, powder, granules, tablets and others. The Companyâs products include central nervous system drugs, hormones and hormone function medicines, respiratory medicines, gastrointestinal drugs, vitamins and others. The Company mainly distributes its products in Taiwan market and the rest of Asia.
JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD. 
